These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31704173)

  • 21. An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.
    Wang Y; He J; Liao M; Hu M; Li W; Ouyang H; Wang X; Ye T; Zhang Y; Ouyang L
    Eur J Med Chem; 2019 Jan; 161():48-77. PubMed ID: 30342425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small Molecules as SIRT Modulators.
    Bai X; Yao L; Ma X; Xu X
    Mini Rev Med Chem; 2018; 18(13):1151-1157. PubMed ID: 27334466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schistosome sirtuins as drug targets.
    Lancelot J; Cabezas-Cruz A; Caby S; Marek M; Schultz J; Romier C; Sippl W; Jung M; Pierce RJ
    Future Med Chem; 2015; 7(6):765-82. PubMed ID: 25996069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirtuin Acetylation and Deacetylation: a Complex Paradigm in Neurodegenerative Disease.
    Khan H; Tiwari P; Kaur A; Singh TG
    Mol Neurobiol; 2021 Aug; 58(8):3903-3917. PubMed ID: 33877561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirtuin activators and inhibitors.
    Villalba JM; Alcaín FJ
    Biofactors; 2012; 38(5):349-59. PubMed ID: 22730114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural Sirtuin Modulators in Drug Discovery: A Review (2010 -2020).
    Chang Y; Yeong KY
    Curr Med Chem; 2021; 28(37):7749-7766. PubMed ID: 33781187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in characterization of human sirtuin isoforms: chemistries, targets and therapeutic applications.
    Cen Y; Youn DY; Sauve AA
    Curr Med Chem; 2011; 18(13):1919-35. PubMed ID: 21517779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticancer agents targeted to sirtuins.
    Kozako T; Suzuki T; Yoshimitsu M; Arima N; Honda S; Soeda S
    Molecules; 2014 Dec; 19(12):20295-313. PubMed ID: 25486244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Franklin H. Epstein Lecture: Sirtuins, aging, and medicine.
    Guarente L
    N Engl J Med; 2011 Jun; 364(23):2235-44. PubMed ID: 21651395
    [No Abstract]   [Full Text] [Related]  

  • 30. Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology.
    Kumar S; Lombard DB
    Crit Rev Biochem Mol Biol; 2018 Jun; 53(3):311-334. PubMed ID: 29637793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirtuin functions and modulation: from chemistry to the clinic.
    Carafa V; Rotili D; Forgione M; Cuomo F; Serretiello E; Hailu GS; Jarho E; Lahtela-Kakkonen M; Mai A; Altucci L
    Clin Epigenetics; 2016; 8():61. PubMed ID: 27226812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
    Neugebauer RC; Sippl W; Jung M
    Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic role of sirtuins in neurodegenerative disease.
    Outeiro TF; Marques O; Kazantsev A
    Biochim Biophys Acta; 2008 Jun; 1782(6):363-9. PubMed ID: 18373985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing metabolic disorders by novel SIRT1 activators.
    Sakamoto K
    Cell Metab; 2008 Jan; 7(1):3-4. PubMed ID: 18177718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation and inhibition of sirtuins: From bench to bedside.
    Fiorentino F; Fabbrizi E; Mai A; Rotili D
    Med Res Rev; 2024 Aug; ():. PubMed ID: 39215785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.
    Nogueiras R; Habegger KM; Chaudhary N; Finan B; Banks AS; Dietrich MO; Horvath TL; Sinclair DA; Pfluger PT; Tschöp MH
    Physiol Rev; 2012 Jul; 92(3):1479-514. PubMed ID: 22811431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirtuins--novel therapeutic targets to treat age-associated diseases.
    Lavu S; Boss O; Elliott PJ; Lambert PD
    Nat Rev Drug Discov; 2008 Oct; 7(10):841-53. PubMed ID: 18827827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.
    Albani D; Polito L; Forloni G
    J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirtuin deacetylases in neurodegenerative diseases of aging.
    Herskovits AZ; Guarente L
    Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Trends in Sirtuin Activator and Inhibitor Development.
    Bursch KL; Goetz CJ; Smith BC
    Molecules; 2024 Mar; 29(5):. PubMed ID: 38474697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.